Elevated soluble urokinase plasminogen activator receptor serum levels indicate poor survival following transarterial chemoembolization therapy for hepatic malignancies: An exploratory analysis

BACKGROUND AND AIM: Transarterial chemoembolization (TACE) represents a standard of care for patients with intermediate‐stage hepatocellular carcinoma (HCC) or liver metastases. However, identification of the ideal candidates for TACE therapy remains challenging. The soluble urokinase plasminogen ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Loosen, Sven H, Schulze‐Hagen, Max, Vucur, Mihael, Gorgulho, Joao, Paffenholz, Pia, Benz, Fabian, Mohr, Raphael, Demir, Münevver, Wree, Alexander, Kuhl, Christiane, Trautwein, Christian, Tacke, Frank, Bruners, Philipp, Luedde, Tom, Roderburg, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936623/
https://www.ncbi.nlm.nih.gov/pubmed/33732882
http://dx.doi.org/10.1002/jgh3.12501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936623/
https://www.ncbi.nlm.nih.gov/pubmed/33732882
http://dx.doi.org/10.1002/jgh3.12501

Ejemplares similares